{
    "componentChunkName": "component---src-templates-docs-js",
    "path": "/",
    "result": {"data":{"site":{"siteMetadata":{"title":"LTA Antistollingszorg"}},"mdx":{"fields":{"id":"c56a825a-0c61-5763-a332-00fcad99b7de","title":"Welkom!","slug":"/"},"body":"var _excluded = [\"components\"];\n\nfunction _extends() { _extends = Object.assign ? Object.assign.bind() : function (target) { for (var i = 1; i < arguments.length; i++) { var source = arguments[i]; for (var key in source) { if (Object.prototype.hasOwnProperty.call(source, key)) { target[key] = source[key]; } } } return target; }; return _extends.apply(this, arguments); }\n\nfunction _objectWithoutProperties(source, excluded) { if (source == null) return {}; var target = _objectWithoutPropertiesLoose(source, excluded); var key, i; if (Object.getOwnPropertySymbols) { var sourceSymbolKeys = Object.getOwnPropertySymbols(source); for (i = 0; i < sourceSymbolKeys.length; i++) { key = sourceSymbolKeys[i]; if (excluded.indexOf(key) >= 0) continue; if (!Object.prototype.propertyIsEnumerable.call(source, key)) continue; target[key] = source[key]; } } return target; }\n\nfunction _objectWithoutPropertiesLoose(source, excluded) { if (source == null) return {}; var target = {}; var sourceKeys = Object.keys(source); var key, i; for (i = 0; i < sourceKeys.length; i++) { key = sourceKeys[i]; if (excluded.indexOf(key) >= 0) continue; target[key] = source[key]; } return target; }\n\n/* @jsxRuntime classic */\n\n/* @jsx mdx */\nvar _frontmatter = {\n  \"title\": \"Welkom!\",\n  \"metaTitle\": \"Introductie\",\n  \"metaDescription\": \"De LTA antistollingszorg geeft richting aan de samenwerking tussen de medisch specialist, huisarts, trombosedienst, openbaar apotheker, specialist ouderengeneeskunde, tandartsen en mondhygiënisten op het gebied van antitrombotica.\",\n  \"date\": \"21-10-2025\",\n  \"type\": \"\",\n  \"nextUrl\": \"/inleiding\",\n  \"nextText\": \"Inleiding\",\n  \"previousUrl\": \"\",\n  \"previousText\": \"\"\n};\n\nvar makeShortcode = function makeShortcode(name) {\n  return function MDXDefaultShortcode(props) {\n    console.warn(\"Component \" + name + \" was not imported, exported, or provided by MDXProvider as global scope\");\n    return mdx(\"div\", props);\n  };\n};\n\nvar Card = makeShortcode(\"Card\");\nvar LinkOutlined = makeShortcode(\"LinkOutlined\");\nvar layoutProps = {\n  _frontmatter: _frontmatter\n};\nvar MDXLayout = \"wrapper\";\nreturn function MDXContent(_ref) {\n  var components = _ref.components,\n      props = _objectWithoutProperties(_ref, _excluded);\n\n  return mdx(MDXLayout, _extends({}, layoutProps, props, {\n    components: components,\n    mdxType: \"MDXLayout\"\n  }), mdx(\"h2\", null, \"Landelijke Transmurale Afspraak (LTA) Antistollingszorg\"), mdx(\"p\", null, \"De landelijke transmurale afspraak (LTA) antistollingszorg geeft richting aan de \", mdx(\"em\", {\n    parentName: \"p\"\n  }, \"samenwerking\"), \" tussen:\"), mdx(\"ul\", null, mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"de medisch specialist\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"huisarts\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"trombosedienst\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"openbaar apotheker\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"specialist ouderengeneeskunde\"), mdx(\"li\", {\n    parentName: \"ul\"\n  }, \"tandartsen en mondhygi\\xEBnisten\")), mdx(\"hr\", null), mdx(\"p\", null, \"Op deze website vindt u onder meer informatie over het voorschrijven en de follow-up\\nvan antitrombotica, periprocedureel beleid en het beleid bij bloedingen. Ook vindt\\nu op deze website informatie over onderwerpen die belangrijk zijn in de communicatie\\nmet pati\\xEBnten. Voor de onderdelen periprocedureel beleid en beleid bij bloedingen\\nzijn beslisbomen ontwikkeld.\"), mdx(NotifyIE, {\n    mdxType: \"NotifyIE\"\n  }), mdx(Divider, {\n    mdxType: \"Divider\"\n  }), mdx(Row, {\n    gutter: 16,\n    mdxType: \"Row\"\n  }, mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    title: \"Initiatief\",\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Nederlandse Internisten Vereniging\",\n      src: \"/img/logo-niv.png\",\n      style: {\n        width: \"100%\",\n        height: \"150px\",\n        objectFit: \"contain\",\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Nederlandse Internisten Vereniging\"), mdx(\"a\", {\n    href: \"https://internisten.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    title: \"Ondersteuning\",\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Kennisinstituut van de Federatie Medisch Specialisten\",\n      src: \"/img/logo-fms.png\",\n      style: {\n        width: \"100%\",\n        height: \"150px\",\n        objectFit: \"contain\",\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Kennisinstituut van de Federatie Medisch Specialisten\"), mdx(\"a\", {\n    href: \"https://www.demedischspecialist.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    title: \"Financiering\",\n    size: \"small\",\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Stichting Kwaliteitsgelden Medisch Specialisten (SKMS)\"), mdx(\"a\", {\n    href: \"https://www.demedischspecialist.nl/onderwerp/skms?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  }))))), mdx(Divider, {\n    mdxType: \"Divider\"\n  }), mdx(\"h2\", null, \"In samenwerking met\"), mdx(Row, {\n    gutter: 16,\n    mdxType: \"Row\"\n  }, mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Nederlandse Vereniging voor Cardiologie\",\n      src: \"/img/logo-nvvc.png\",\n      style: {\n        width: '100%',\n        height: '100px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Nederlandse Vereniging voor Cardiologie\"), mdx(\"a\", {\n    href: \"https://www.nvvc.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Nederlands Huisartsen Genootschap\",\n      src: \"/img/logo-nhg.png\",\n      style: {\n        width: '100%',\n        height: '100px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Nederlands Huisartsen Genootschap\"), mdx(\"a\", {\n    href: \"https://www.nhg.org?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  })))), mdx(Col, {\n    span: 8,\n    mdxType: \"Col\"\n  }, mdx(Card, {\n    size: \"small\",\n    cover: mdx(\"img\", {\n      alt: \"Harteraad\",\n      src: \"/img/logo-harteraad.png\",\n      style: {\n        width: '100%',\n        height: '100px',\n        objectFit: 'contain',\n        padding: \"10%\",\n        backgroundColor: \"#fafafa\"\n      }\n    }),\n    mdxType: \"Card\"\n  }, mdx(\"h4\", null, \"Harteraad\"), mdx(\"a\", {\n    href: \"https://www.harteraad.nl?utm_source=lta-antistollingszorg\",\n    target: \"_blank\",\n    rel: \"noreferrer noopener\"\n  }, mdx(LinkOutlined, {\n    mdxType: \"LinkOutlined\"\n  }))))));\n}\n;\nMDXContent.isMDXComponent = true;","tableOfContents":{"items":[{"url":"#landelijke-transmurale-afspraak-lta-antistollingszorg","title":"Landelijke Transmurale Afspraak (LTA) Antistollingszorg"},{"url":"#in-samenwerking-met","title":"In samenwerking met"}]},"parent":{"relativePath":"index.mdx"},"frontmatter":{"parent":null,"date":"21-10-2025","nextUrl":"/inleiding","nextText":"Inleiding","previousUrl":"","previousText":""}},"allMdx":{"edges":[{"node":{"fields":{"slug":"/afbakening","title":"Afbakening"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica","title":"Bloedingen onder antitrombotica"}}},{"node":{"fields":{"slug":"/colofon","title":"Colofon"}}},{"node":{"fields":{"slug":"/contact","title":"Contact"}}},{"node":{"fields":{"slug":"/","title":"Welkom!"}}},{"node":{"fields":{"slug":"/inleiding","title":"Inleiding"}}},{"node":{"fields":{"slug":"/literatuur","title":"Literatuur"}}},{"node":{"fields":{"slug":"/colofon/afkortingenlijst","title":"Afkortingenlijst"}}},{"node":{"fields":{"slug":"/colofon/verantwoording","title":"Verantwoording"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/gezamenlijke-besluitvorming","title":"Gezamenlijke besluitvorming"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/therapietrouw","title":"Therapietrouw"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/veelgestelde-vragen-over-doacs","title":"Veelgestelde vragen over DOACs"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/veelgestelde-vragen-over-vka","title":"Veelgestelde vragen over VKA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/extra-opmerkingen-endoscopische-ingrepen","title":"Extra opmerkingen endoscopische ingrepen"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/extra-opmerkingen-tandheelkundige-ingrepen","title":"Extra opmerkingen tandheelkundige ingrepen"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/overzicht-periprocedureel-bloedingsrisico","title":"Overzicht periprocedureel bloedingsrisico"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/hoog-complexe-antistolling","title":"Hoog complexe antistolling"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/laag-complexe-antistolling","title":"Laag complexe antistolling"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-dabigatran","title":"Beslisboom DOAC - dabigatran"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-factor-xa-remmers-rivaroxaban-apixaban-edoxaban","title":"Beslisboom DOAC - factor Xa-remmers, Rivaroxaban, Apixaban, Edoxaban"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-tar","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-vka","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/algemene-informatie","title":"Algemene informatie"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-beleid-bij-bloedingen-voor-de-huisarts","title":"Beslisboom Beleid bij bloedingen voor de huisarts"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-doac","title":"Beslisboom DOAC"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-tar","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-vka","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/bloeding-onder-lmwh-ongefractioneerde-heparine","title":"Bloeding onder LMWH/ ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-apixaban","title":"Beslisboom Apixaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-dabigatran","title":"Beslisboom Dabigatran"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-edoxaban","title":"Beslisboom Edoxaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-rivaroxaban","title":"Beslisboom Rivaroxaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-dipyridamol","title":"Beslisboom DAPT ASA en dipyridamol"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-prasugrel-clopidogrel-ticagrelor","title":"Beslisboom DAPT ASA en prasugrel, clopidogrel, ticagrelor"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-monotherapie-clopidogrel-of-asa","title":"Beslisboom monotherapie Clopidogrel of ASA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/dual-antiplatelet-therapy-dapt-behandeling","title":"Dual Antiplatelet Therapy (DAPT) behandeling"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/minimale-duur-onderbreken-en-herstarten-dapt","title":"Minimale duur onderbreken en herstarten DAPT"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/vka/aanbevelingen-overbrugging-en-herstarten-vka","title":"Aanbevelingen overbrugging en herstarten VKA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/vka/beslisboom-vka","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/doac/follow-up-controles","title":"Follow-up controles"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/doac/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/lmwh/dosering-lmwh-bij-verminderde-nierfunctie","title":"Dosering LMWH bij verminderde nierfunctie"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/lmwh/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/tar/follow-up-controles","title":"Follow-up controles"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/tar/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/vka/follow-up-controles","title":"Follow-up controles"}}},{"node":{"fields":{"slug":"/voorschrijven-en-follow-up/vka/overzicht","title":"Overzicht"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-dabigatran/schematisch","title":"Beslisboom DOAC- dabigatran"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-doac-factor-xa-remmers-rivaroxaban-apixaban-edoxaban/schematisch","title":"Beslisboom DOAC - factor Xa-remmers, Rivaroxaban, Apixaban, Edoxaban"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine/schematisch","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-tar/schematisch","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/ernstige-bloedingen/beslisboom-vka/schematisch","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-beleid-bij-bloedingen-voor-de-huisarts/schematisch","title":"Beslisboom Beleid bij bloedingen voor de huisarts"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-doac/schematisch","title":"Beslisboom DOAC"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-lmwh-ongefractioneerde-heparine/schematisch","title":"Beslisboom LMWH/ongefractioneerde heparine"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-tar/schematisch","title":"Beslisboom TAR"}}},{"node":{"fields":{"slug":"/bloedingen-onder-antitrombotica/niet-ernstige-bloedingen/beslisboom-vka/schematisch","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-apixaban/schematisch","title":"Beslisboom Apixaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-dabigatran/schematisch","title":"Beslisboom Dabigatran"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-edoxaban/schematisch","title":"Beslisboom Edoxaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/doac/beslisboom-rivaroxaban/schematisch","title":"Beslisboom Rivaroxaban"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-dipyridamol/schematisch","title":"Beslisboom DAPT ASA en dipyridamol"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-dapt-asa-en-prasugrel-clopidogrel-ticagrelor/schematisch","title":"Beslisboom DAPT ASA en prasugrel, clopidogrel, ticagrelor"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/tar/beslisboom-monotherapie-clopidogrel-of-asa/schematisch","title":"Beslisboom monotherapie Clopidogrel of ASA"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/vka/beslisboom-vka/schematisch","title":"Beslisboom VKA"}}},{"node":{"fields":{"slug":"/changelog","title":"Changelog"}}},{"node":{"fields":{"slug":"/communicatie-met-patienten/informatievoorziening","title":"Informatievoorziening"}}},{"node":{"fields":{"slug":"/periprocedureel-beleid/overzicht-trombo-embolie-risico","title":"Overzicht trombo-embolie risico"}}}]}},"pageContext":{"id":"c56a825a-0c61-5763-a332-00fcad99b7de"}},
    "staticQueryHashes": ["1620603387","2744294623","3578633366","3706406642","4066733661"]}